Peder Charles , Leif Mosekilde , Leila Risteli , Juha Risteli , Erik Fink Eriksen
{"title":"用I型胶原合成和降解的生化指标评估骨重塑:与钙动力学的关系","authors":"Peder Charles , Leif Mosekilde , Leila Risteli , Juha Risteli , Erik Fink Eriksen","doi":"10.1016/S0169-6009(08)80147-X","DOIUrl":null,"url":null,"abstract":"<div><p>In this study, we investigated the relation between calcium kinetic indices of bone remodeling (resorption rate, <em>r</em>; and formation rate, <em>m</em>, respectively) and two serum markers of type I collagen turnover: the pyridinoline cross-linked carboxyterminal telopeptide domains of type I collagen (<em>S</em>-ICTP a marker of bone matrix degradation) and the carboxyterminal propeptide of human type I procollagen (<em>S</em>-PICP, a marker of bone matrix formation). We studied three groups: (i) healthy controls (<em>n</em> = 19), (ii) a mixed group of high and low-turnover bone diseases without mineralization defects (myxedema, thyrotoxicosis and primary hyperparathyroidism <em>n</em> = 38), and (iii) osteoporosis (<em>n</em> = 52). In healthy controls, a significant regression of <em>S</em>-PICP on <em>m</em> was obtained (<em>R</em> = 0.53, SEE/Y = 0.44, <em>P</em> < 0.02). Significant regressions were also demonstrable in high- and low-turnover bone disease (<em>R</em> = 0.50, <em>P</em> < 0.001), SEE/Y = 61%) and osteoporosis (<em>R</em> = 0.49, <em>P</em> < 0.001, SEE/Y = 50%). In controls the regression coefficient for the regression of <em>S</em>-ICTP on <em>r</em> was 0.19 (NS), in high and low turnover bone disease 0.66, (SEE/Y = 59%, <em>P</em> < 0.001) and in the osteoporotic group 0.40 (SEE/Y = 61%, <em>P</em> < 0.01). We conclude that <em>S</em>-PICP and <em>S</em>-ICTP reflect whole skeletal bone formation and resorption rates in a variety of metabolic bone diseases including osteoporosis.</p></div>","PeriodicalId":77047,"journal":{"name":"Bone and mineral","volume":"24 2","pages":"Pages 81-94"},"PeriodicalIF":0.0000,"publicationDate":"1994-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0169-6009(08)80147-X","citationCount":"116","resultStr":"{\"title\":\"Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics\",\"authors\":\"Peder Charles , Leif Mosekilde , Leila Risteli , Juha Risteli , Erik Fink Eriksen\",\"doi\":\"10.1016/S0169-6009(08)80147-X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In this study, we investigated the relation between calcium kinetic indices of bone remodeling (resorption rate, <em>r</em>; and formation rate, <em>m</em>, respectively) and two serum markers of type I collagen turnover: the pyridinoline cross-linked carboxyterminal telopeptide domains of type I collagen (<em>S</em>-ICTP a marker of bone matrix degradation) and the carboxyterminal propeptide of human type I procollagen (<em>S</em>-PICP, a marker of bone matrix formation). We studied three groups: (i) healthy controls (<em>n</em> = 19), (ii) a mixed group of high and low-turnover bone diseases without mineralization defects (myxedema, thyrotoxicosis and primary hyperparathyroidism <em>n</em> = 38), and (iii) osteoporosis (<em>n</em> = 52). In healthy controls, a significant regression of <em>S</em>-PICP on <em>m</em> was obtained (<em>R</em> = 0.53, SEE/Y = 0.44, <em>P</em> < 0.02). Significant regressions were also demonstrable in high- and low-turnover bone disease (<em>R</em> = 0.50, <em>P</em> < 0.001), SEE/Y = 61%) and osteoporosis (<em>R</em> = 0.49, <em>P</em> < 0.001, SEE/Y = 50%). In controls the regression coefficient for the regression of <em>S</em>-ICTP on <em>r</em> was 0.19 (NS), in high and low turnover bone disease 0.66, (SEE/Y = 59%, <em>P</em> < 0.001) and in the osteoporotic group 0.40 (SEE/Y = 61%, <em>P</em> < 0.01). We conclude that <em>S</em>-PICP and <em>S</em>-ICTP reflect whole skeletal bone formation and resorption rates in a variety of metabolic bone diseases including osteoporosis.</p></div>\",\"PeriodicalId\":77047,\"journal\":{\"name\":\"Bone and mineral\",\"volume\":\"24 2\",\"pages\":\"Pages 81-94\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1994-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0169-6009(08)80147-X\",\"citationCount\":\"116\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bone and mineral\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S016960090880147X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone and mineral","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S016960090880147X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 116
摘要
在这项研究中,我们研究了骨重塑的钙动力学指标(吸收速率,r;和形成率,m)和两种I型胶原转换的血清标志物:I型胶原的吡啶啉交联羧基末端末端肽域(S-ICTP,骨基质降解标志物)和人I型前胶原的羧基末端前肽(S-PICP,骨基质形成标志物)。我们研究了三组:(i)健康对照(n = 19), (ii)无矿化缺陷的高低转换骨病混合组(粘液水肿、甲状腺毒症和原发性甲状旁腺功能亢进n = 38),以及(iii)骨质疏松症(n = 52)。在健康对照组中,S-PICP对m有显著回归(R = 0.53, SEE/Y = 0.44, P <0.02)。高周转率骨病和低周转率骨病也有显著回归(R = 0.50, P <0.001), SEE/Y = 61%)和骨质疏松症(R = 0.49, P <0.001,见/ y = 50%)。对照组S-ICTP对r的回归系数为0.19 (NS),高、低周转率骨病的回归系数为0.66,(SEE/Y = 59%, P <0.001),骨质疏松组为0.40 (SEE/Y = 61%, P <0.01)。我们得出结论,S-PICP和S-ICTP反映了包括骨质疏松症在内的多种代谢性骨病的全骨形成和骨吸收率。
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics
In this study, we investigated the relation between calcium kinetic indices of bone remodeling (resorption rate, r; and formation rate, m, respectively) and two serum markers of type I collagen turnover: the pyridinoline cross-linked carboxyterminal telopeptide domains of type I collagen (S-ICTP a marker of bone matrix degradation) and the carboxyterminal propeptide of human type I procollagen (S-PICP, a marker of bone matrix formation). We studied three groups: (i) healthy controls (n = 19), (ii) a mixed group of high and low-turnover bone diseases without mineralization defects (myxedema, thyrotoxicosis and primary hyperparathyroidism n = 38), and (iii) osteoporosis (n = 52). In healthy controls, a significant regression of S-PICP on m was obtained (R = 0.53, SEE/Y = 0.44, P < 0.02). Significant regressions were also demonstrable in high- and low-turnover bone disease (R = 0.50, P < 0.001), SEE/Y = 61%) and osteoporosis (R = 0.49, P < 0.001, SEE/Y = 50%). In controls the regression coefficient for the regression of S-ICTP on r was 0.19 (NS), in high and low turnover bone disease 0.66, (SEE/Y = 59%, P < 0.001) and in the osteoporotic group 0.40 (SEE/Y = 61%, P < 0.01). We conclude that S-PICP and S-ICTP reflect whole skeletal bone formation and resorption rates in a variety of metabolic bone diseases including osteoporosis.